Vertex Pharmaceuticals Inc
€376.18
EUR
Last updated on --.
24h volume459.50K
24h highest379.39 EUR
24h lowest373.59 EUR
24h Price movement+0.63%
VRTX recent prices
24 Hours
+0.63%+€2.370
30 days
+2.33%+€8.552
60 days
+0.34%+€1.277
90 days
-9.20%-€38.01
Key data
Previous close373.82 EUR
Market cap93.99B EUR
Volume459.50K
P/E ratio25.180000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)14.7025 EUR
Net income (FY)3.73B EUR
Revenue (FY)10.51B EUR
Last report date5 May 2026
About Vertex Pharmaceuticals Inc
HeadquartersBOSTON
Employees (FY)6.40K
Revenue per employee (FY)1.64M EUR
Net income per employee (FY)583.16K EUR
Listed onNasdaq
VRTX conversion tables
 |  |
|---|---|
| 0.5 VRTX | 188.09 EUR |
| 1 VRTX | 376.18 EUR |
| 5 VRTX | 1,880.93 EUR |
| 10 VRTX | 3,761.87 EUR |
| |
|---|---|
| 0.5 EUR | 0.0013291 VRTX |
| 1 EUR | 0.0026582 VRTX |
| 5 EUR | 0.013291 VRTX |
| 10 EUR | 0.026582 VRTX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
VRTX is trading at €376.18, +0.63% over the last 24 hours. Track live moves on the price chart at the top of this page.
The VRTX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. VRTX is currently trading at €376.18, +0.63% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on VRTX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. VRTX's P/E ratio is currently 25.180000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from VRTX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against VRTX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Vertex Pharmaceuticals Inc's market cap is currently 93.99B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume459.50K
24h highest379.39 EUR
24h lowest373.59 EUR
24h Price movement+0.63%
Start trade with VRTX Perpetual
Sign up to trade